In recent years, several cytokines have been proven especially promising as potential therapeutic targets for experimental ischemic stroke including the tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and the anti-inflammatory cytokine-10 (IL-10; Zhang et al., 2017; Lambertsen et al., 2019). Here, IL6 is linked to ischemic stroke.